Tender germany-hanover: antineoplastic and-1350729

This tender with title Germany-Hanover: Antineoplastic and immunomodulating agents has been published on Bidding Source portal dated 17 Oct 2018 for the country of Germany. It has been categorized on Antineoplastic and immunomodulating agents. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

Germany-Hanover: Antineoplastic and immunomodulating agents

Tender Type :

Contract notice

Reference No. :

2018/S 200-454140

Country :

Germany

Province/City :

Germany-Hanover

Publish Date :

17 Oct 2018

Closing Date :

27 Sep 2020

Notice Language :

English

Tender Categories (CPVs) :

Antineoplastic and immunomodulating agents

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 6002636912-Diverse Impfstoffe - 296319-2024 Germany General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – TBE vaccine and rabies vaccine - 254089-2024 Germany Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for medicines with the active ingredient glatiramer acetate (ATC code: L03AX13), with the exception of the dosage form pre-filled pen (PEN). Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Golimumab (ATC-Code: L04AB06). -- <h6>Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products with the active ingredient golimumab (ATC code: L04AB06).</h6> Germany Conclusion of a non-exclusive discount agreement in accordance with § 130a Paragraph 8 SGB V for medicinal products with the active ingredient rituximab (ATC code: L01FA01). Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Dasatinib (ATC-Code: L01EA02). -- Antineoplastic and immunomodulating agents Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Pegfilgrastim (ATC-Code: L03AA13). -- Antineoplastic and immunomodulating agents Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Filgrastim (ATC-Code: L03AA02). -- Antineoplastic and immunomodulating agents Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Goserelin (ATC-Code: L02AE03). -- Antineoplastic and immunomodulating agents Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Lenograstim (ATC-Code: L03AA10) -- Antineoplastic and immunomodulating agents Germany

Germany-Hanover: Antineoplastic and immunomodulating agents

General Information

Germany

Similar Tenders

Antineoplastic and immunomodulating agents Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com